Company Filing History:
Years Active: 2013-2019
Title: Andrea E Edling: Innovator in Peptide Analog Research
Introduction
Andrea E Edling is a prominent inventor based in Milford, MA (US). She has made significant contributions to the field of peptide analogs, particularly in relation to alpha-melanocyte stimulating hormone (α-MSH). With a total of 4 patents to her name, Edling's work has implications for both medical and veterinary treatments.
Latest Patents
One of her latest patents focuses on stable peptide analogs of the native α-MSH, which exhibit selectivity for the melanocortin 1 receptor (MC1R). This innovation includes pharmaceutical preparations of the α-MSH peptide analogs, as well as methods for utilizing these analogs in treating various medical and veterinary conditions involving MC1R. The potential applications of her research are vast and could lead to advancements in therapeutic strategies.
Career Highlights
Andrea Edling is associated with Genzyme Corporation, where she continues to push the boundaries of peptide research. Her work has garnered attention in the scientific community, and her patents reflect her commitment to innovation in this specialized field.
Collaborations
Throughout her career, Edling has collaborated with notable colleagues, including Michael A Perricone and John Lyle Dzuris. These partnerships have likely contributed to the depth and breadth of her research endeavors.
Conclusion
Andrea E Edling stands out as a key figure in the development of peptide analogs, with her innovative work paving the way for future advancements in medical treatments. Her contributions to the field are invaluable and continue to inspire further research.